Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Järbe TU[au]:

A novel probe for the cannabinoid receptor. Devane WA et al. J Med Chem. (1992)

Discriminative stimulus functions of cannabinoids/cannabimimetics. Järbe TU et al. NIDA Res Monogr. (1991)

Characteristics of tetrahydrocannabinol (THC)-produced discrimination in rats. Järbe TU et al. Psychopharmacology (Berl). (1976)

Search results

Items: 1 to 50 of 132

1.

Tripping with Synthetic Cannabinoids ("Spice"): Anecdotal and Experimental Observations in Animals and Man.

Järbe TUC, Raghav JG.

Curr Top Behav Neurosci. 2017;32:263-281. doi: 10.1007/7854_2016_16. Review.

PMID:
27753006
2.

Novel C-Ring-Hydroxy-Substituted Controlled Deactivation Cannabinergic Analogues.

Kulkarni S, Nikas SP, Sharma R, Jiang S, Paronis CA, Leonard MZ, Zhang B, Honrao C, Mallipeddi S, Raghav JG, Benchama O, Järbe TU, Bergman J, Makriyannis A.

J Med Chem. 2016 Jul 28;59(14):6903-19. doi: 10.1021/acs.jmedchem.6b00717. Epub 2016 Jul 13.

3.

A high efficacy cannabinergic ligand (AM4054) used as a discriminative stimulus: Generalization to other adamantyl analogs and Δ(9)-THC in rats.

Järbe TU, LeMay BJ, Thakur GA, Makriyannis A.

Pharmacol Biochem Behav. 2016 Sep;148:46-52. doi: 10.1016/j.pbb.2016.06.001. Epub 2016 Jun 2.

4.

[INCREMENT]9-Tetrahydrocannabinol discriminative stimulus effects of AM2201 and related aminoalkylindole analogs in rats.

Järbe TU, Gifford RS, Zvonok A, Makriyannis A.

Behav Pharmacol. 2016 Apr;27(2-3 Spec Issue):211-4. doi: 10.1097/FBP.0000000000000196.

5.

Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist.

Tai S, Nikas SP, Shukla VG, Vemuri K, Makriyannis A, Järbe TU.

Psychopharmacology (Berl). 2015 Aug;232(15):2751-61. doi: 10.1007/s00213-015-3907-0. Epub 2015 Mar 15.

6.

Probing the carboxyester side chain in controlled deactivation (-)-δ(8)-tetrahydrocannabinols.

Nikas SP, Sharma R, Paronis CA, Kulkarni S, Thakur GA, Hurst D, Wood JT, Gifford RS, Rajarshi G, Liu Y, Raghav JG, Guo JJ, Järbe TU, Reggio PH, Bergman J, Makriyannis A.

J Med Chem. 2015 Jan 22;58(2):665-81. doi: 10.1021/jm501165d. Epub 2014 Dec 16.

7.

Controlled-deactivation cannabinergic ligands.

Sharma R, Nikas SP, Paronis CA, Wood JT, Halikhedkar A, Guo JJ, Thakur GA, Kulkarni S, Benchama O, Raghav JG, Gifford RS, Järbe TU, Bergman J, Makriyannis A.

J Med Chem. 2013 Dec 27;56(24):10142-57. doi: 10.1021/jm4016075. Epub 2013 Dec 10.

8.

Differentiation between low- and high-efficacy CB1 receptor agonists using a drug discrimination protocol for rats.

Järbe TU, LeMay BJ, Halikhedkar A, Wood J, Vadivel SK, Zvonok A, Makriyannis A.

Psychopharmacology (Berl). 2014 Feb;231(3):489-500. doi: 10.1007/s00213-013-3257-8. Epub 2013 Sep 5.

9.

"Herbal incense": designer drug blends as cannabimimetics and their assessment by drug discrimination and other in vivo bioassays.

Järbe TU, Gifford RS.

Life Sci. 2014 Feb 27;97(1):64-71. doi: 10.1016/j.lfs.2013.07.011. Epub 2013 Jul 25. Review.

10.

AM2389, a high-affinity, in vivo potent CB1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice.

Järbe TU, Tai S, LeMay BJ, Nikas SP, Shukla VG, Zvonok A, Makriyannis A.

Psychopharmacology (Berl). 2012 Mar;220(2):417-26. doi: 10.1007/s00213-011-2491-1. Epub 2011 Oct 12.

11.

Cannabinergic aminoalkylindoles, including AM678=JWH018 found in 'Spice', examined using drug (Δ(9)-tetrahydrocannabinol) discrimination for rats.

Järbe TU, Deng H, Vadivel SK, Makriyannis A.

Behav Pharmacol. 2011 Sep;22(5-6):498-507. doi: 10.1097/FBP.0b013e328349fbd5.

12.

Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats.

Järbe TU, LeMay BJ, Vemuri VK, Vadivel SK, Zvonok A, Makriyannis A.

Psychopharmacology (Berl). 2011 Aug;216(3):355-65. doi: 10.1007/s00213-011-2226-3. Epub 2011 Mar 3.

13.

Antagonism of ∆⁹-THC induced behavioral effects by rimonabant: time course studies in rats.

Järbe TU, Gifford RS, Makriyannis A.

Eur J Pharmacol. 2010 Dec 1;648(1-3):133-8. doi: 10.1016/j.ejphar.2010.09.006. Epub 2010 Sep 18.

14.

Transfer of the discriminative stimulus effects of Δ9-THC and nicotine from one operant response to another in rats.

Troisi JR 2nd, LeMay BJ, Järbe TU.

Psychopharmacology (Berl). 2010 Oct;212(2):171-9. doi: 10.1007/s00213-010-1940-6. Epub 2010 Jul 14.

PMID:
20628732
15.

Discriminative stimulus functions of methanandamide and delta(9)-THC in rats: tests with aminoalkylindoles (WIN55,212-2 and AM678) and ethanol.

Järbe TU, Li C, Vadivel SK, Makriyannis A.

Psychopharmacology (Berl). 2010 Jan;208(1):87-98. doi: 10.1007/s00213-009-1708-z. Epub 2009 Nov 10.

16.

Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.

Järbe TU, LeMay BJ, Olszewska T, Vemuri VK, Wood JT, Makriyannis A.

Pharmacol Biochem Behav. 2008 Nov;91(1):84-90. doi: 10.1016/j.pbb.2008.06.014. Epub 2008 Jun 29.

17.

Discriminative stimulus functions in rats of AM1346, a high-affinity CB1R selective anandamide analog.

Järbe TU, Li C, Liu Q, Makriyannis A.

Psychopharmacology (Berl). 2009 Apr;203(2):229-39. doi: 10.1007/s00213-008-1199-3. Epub 2008 Jun 3.

18.

Discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats.

Järbe TU, Li C, Vadivel SK, Makriyannis A.

Psychopharmacology (Berl). 2008 Jul;198(4):467-78. doi: 10.1007/s00213-008-1076-0. Epub 2008 Feb 9.

19.

Effects of AM1346, a high-affinity CB1 receptor selective anandamide analog, on open-field behavior in rats.

Järbe TU, DiPatrizio NV, Li C, Makriyannis A.

Behav Pharmacol. 2007 Nov;18(7):673-80.

PMID:
17912052
20.

Effects of the CB1R agonist WIN-55,212-2 and the CB1R antagonists SR-141716 and AM-1387: open-field examination in rats.

Järbe TU, Ross T, DiPatrizio NV, Pandarinathan L, Makriyannis A.

Pharmacol Biochem Behav. 2006 Sep;85(1):243-52. Epub 2006 Sep 22.

PMID:
16996123
21.

Discriminative stimulus functions of AM-1346, a CB1R selective anandamide analog in rats trained with Delta9-THC or (R)-methanandamide (AM-356).

Järbe TU, Lamb RJ, Liu Q, Makriyannis A.

Psychopharmacology (Berl). 2006 Oct;188(3):315-23. Epub 2006 Sep 5.

PMID:
16953384
22.

Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats.

Järbe TU, Liu Q, Makriyannis A.

Psychopharmacology (Berl). 2006 Jan;184(1):36-45. Epub 2005 Nov 24.

PMID:
16307294
24.

Adamantyl cannabinoids: a novel class of cannabinergic ligands.

Lu D, Meng Z, Thakur GA, Fan P, Steed J, Tartal CL, Hurst DP, Reggio PH, Deschamps JR, Parrish DA, George C, Järbe TU, Lamb RJ, Makriyannis A.

J Med Chem. 2005 Jul 14;48(14):4576-85.

PMID:
15999995
25.
26.

Discriminative stimulus effects in rats of SR-141716 (rimonabant), a cannabinoid CB1 receptor antagonist.

Järbe TU, Harris MY, Li C, Liu Q, Makriyannis A.

Psychopharmacology (Berl). 2004 Dec;177(1-2):35-45. Epub 2004 May 27.

PMID:
15167981
27.
28.

(R)-Methanandamide and delta9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A.

Järbe TU, Lamb RJ, Liu Q, Makriyannis A.

Eur J Pharmacol. 2003 Apr 11;466(1-2):121-7.

PMID:
12679148
29.

Interactions between the CB1 receptor agonist Delta 9-THC and the CB1 receptor antagonist SR-141716 in rats: open-field revisited.

Järbe TU, Andrzejewski ME, DiPatrizio NV.

Pharmacol Biochem Behav. 2002 Nov;73(4):911-9.

PMID:
12213538
30.
31.

Effects of fluvoxamine on ethanol-reinforced behavior in the rat.

Lamb RJ, Järbe TU.

J Pharmacol Exp Ther. 2001 Jun;297(3):1001-9.

PMID:
11356922
32.

Effects of Delta 9-tetrahydrocannabinol, (R)-methanandamide, SR 141716,and d-amphetamine before and during daily Delta 9-tetrahydrocannabinol dosing.

Lamb RJ, Järbe TU, Makriyannis A, Lin S, Goutopoulos A.

Eur J Pharmacol. 2000 Jun 16;398(2):251-8.

PMID:
10854837
33.

Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats: a systematic replication.

Järbe TU, Lamb RJ, Lin S, Makriyannis A.

Behav Pharmacol. 2000 Feb;11(1):81-6.

PMID:
10821212
35.

Discriminated taste aversion and context: a progress report.

Järbe TU, Lamb RJ.

Pharmacol Biochem Behav. 1999 Oct;64(2):403-7.

PMID:
10515321
36.

Effects of delta-9-tetrahydrocannabinol and (R)-methanandamide on open-field behavior in rats.

Järbe TU, Sheppard R, Lamb RJ, Makriyannis A, Lin S, Goutopoulos A.

Behav Pharmacol. 1998 Mar;9(2):169-74.

PMID:
10065936
37.

Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats.

Järbe TU, Lamb RJ, Makriyannis A, Lin S, Goutopoulos A.

Psychopharmacology (Berl). 1998 Dec;140(4):519-22.

PMID:
9888629
38.
39.
40.

Discriminated conditioned taste aversion for studying multi-element stimulus control.

Järbe TU, Lamb RJ.

Behav Pharmacol. 1995 Mar;6(2):149-155.

PMID:
11224322
41.
42.
43.
44.

Discriminative stimulus effects and receptor binding of enantiomeric pairs of cannabinoids in rats and pigeons; a comparison.

Järbe TU, Hiltunen AJ, Mathis DA, Hanŭs L, Breuer A, Mechoulam R.

J Pharmacol Exp Ther. 1993 Feb;264(2):561-9.

PMID:
8382275
45.

A novel probe for the cannabinoid receptor.

Devane WA, Breuer A, Sheskin T, Järbe TU, Eisen MS, Mechoulam R.

J Med Chem. 1992 May 29;35(11):2065-9.

PMID:
1317925
46.

Acute and chronic ethanol tolerance: operant behaviour in naive and ethanol tolerant rats.

Hiltunen AJ, Järbe TU.

Psychopharmacology (Berl). 1992;107(4):511-6.

PMID:
1603893
47.

Reversal of a drug versus drug discrimination task with different exteroceptive conditions.

Rijnders HJ, Järbe TU, Slangen JL.

Behav Pharmacol. 1991 Nov;2(4 And 5):429-435.

PMID:
11224085
48.

The pentylenetetrazole-cue antagonist actions of bretazenil (Ro 16-6028) as compared to midazolam.

Rijnders HJ, Järbe TU, Slangen JL.

Pharmacol Biochem Behav. 1991 May;39(1):129-32.

PMID:
1924494
49.

Discriminative stimulus functions of cannabinoids/cannabimimetics.

Järbe TU, Mathis DA.

NIDA Res Monogr. 1991;(116):75-99. Review. No abstract available.

PMID:
1369683
50.

Cannabimimetic activity of novel enantiomeric, benzofuran cannabinoids.

Mechoulam R, Breuer A, Järbe TU, Hiltunen AJ, Glaser R.

J Med Chem. 1990 Mar;33(3):1037-43.

PMID:
2155318

Supplemental Content

Loading ...
Support Center